Additionally, HDFC Securities has assigned an ‘add’ rating to Max Healthcare Institute, Dr. Lal PathLabs, and Metropolis Healthcare, with price targets of ₹900, ₹2,700, and ₹2,010, respectively. The brokerage anticipates that India’s healthcare sector is on track for continuous expansion, driven by factors such as an aging population, a rise […]
dr lal pathlabs
The industry saw some growth impact during COVID in FY21 as it grew 10% YoY to ₹8 lakh crore and subsequently a bounce-back in FY22, growing 15% YoY to ₹9.2 lakh crore, and normalized growth in FY23 at 15% YoY to ₹10 lakh crore. Going ahead, key structural drivers such […]